000 02605 a2200769 4500
005 20250517193550.0
264 0 _c20190924
008 201909s 0 0 eng d
022 _a2040-2058
024 7 _a10.3851/IMP3218
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeters, Lars
245 0 0 _aUptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.
_h[electronic resource]
260 _bAntiviral therapy
_c2018
300 _a405-413 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdenine
_xanalogs & derivatives
650 0 4 _aAdult
650 0 4 _aAnti-Retroviral Agents
_xtherapeutic use
650 0 4 _aAntiretroviral Therapy, Highly Active
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCoinfection
650 0 4 _aDNA, Viral
_xantagonists & inhibitors
650 0 4 _aDrug Resistance, Viral
_xdrug effects
650 0 4 _aDrug Utilization
_xstatistics & numerical data
650 0 4 _aEurope
650 0 4 _aFemale
650 0 4 _aGuanine
_xanalogs & derivatives
650 0 4 _aHIV
_xdrug effects
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHepatitis B Surface Antigens
_xblood
650 0 4 _aHepatitis B virus
_xdrug effects
650 0 4 _aHepatitis B, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aLamivudine
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOrganophosphonates
_xtherapeutic use
650 0 4 _aPolyethylene Glycols
_xtherapeutic use
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aProspective Studies
650 0 4 _aRecombinant Proteins
_xtherapeutic use
650 0 4 _aTenofovir
_xtherapeutic use
700 1 _aMocroft, Amanda
700 1 _aGrint, Daniel
700 1 _aMoreno, Santiago
700 1 _aCalmy, Alexandra
700 1 _aJevtovic, Djordje
700 1 _aSambatakou, Helen
700 1 _aLacombe, Karine
700 1 _aDe Wit, Stephane
700 1 _aRockstroh, Jürgen
700 1 _aSmidt, Jelena
700 1 _aKarpov, Igor
700 1 _aGrzeszczuk, Anna
700 1 _aHaziosmanovic, Vesnadarjan
700 1 _aGottfredsson, Magnus
700 1 _aRadoi, Roxana
700 1 _aKuzovatova, Elena
700 1 _aOrkin, Chloe
700 1 _aRidolfo, Anna Lisa
700 1 _aZapirain, Jose
700 1 _aLundgren, Jens
773 0 _tAntiviral therapy
_gvol. 23
_gno. 5
_gp. 405-413
856 4 0 _uhttps://doi.org/10.3851/IMP3218
_zAvailable from publisher's website
999 _c27950284
_d27950284